Advanced RCC: Clinical implementation of targeted therapies and immunotherapies

December 06, 2023 • 00:19:51
Advanced RCC: Clinical implementation of targeted therapies and immunotherapies
COR2ED - Oncology Medical Conversation
Advanced RCC: Clinical implementation of targeted therapies and immunotherapies

Dec 06 2023 | 00:19:51

/

Show Notes

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of Brest and Quimper in France, discuss the clinical implementation of targeted and immunotherapies for advanced renal cell carcinoma (RCC).

In this podcast, the two experts discuss data from key trials CHECKMATE 214 (ipilimumab and nivolumab), KEYNOTE 426 (axitinib and pembrolizumab), CHECKMATE 9ER (cabozantinib and nivolumab), CLEAR (Lenvatinib and pembrolizumab) and COSMIC 313 (cabozantinib plus nivolumab and ipilimumab) and the implications for clinical practice.

They also discuss management of toxicities associated with combination treatments, including dosing strategies to ensure the patient remains on optimal treatment and improved education for patients and clinicians so that they recognise side effects and how to manage them.

Other Episodes

Episode

December 06, 2023 • 00:24:55
Episode Cover

Precision oncology: An introduction to molecular testing

This podcast episode provides an introduction to molecular testing in the diagnosis and treatment of cancer.  Prof. David Hong from MD Anderson Cancer Center,...

Listen

Episode

December 06, 2023 • 00:27:20
Episode Cover

Managing thrombosis: Part 2 - Cancer and thrombosis

In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between...

Listen

Episode

April 25, 2024 • 00:29:54
Episode Cover

Cáncer de próstata: dificultades en la fase preanalítica y pruebas de biomarcadores

¿Cuáles son los desafíos frecuentes en la fase preanalítica del cáncer de próstata, y cómo podemos superarlos? ¿Por qué es importante identificar las alteraciones...

Listen